Skip to content

A comparative study of different fluid therapy in blood separation of cardiac aortic surgery

A comparative study of different fluid therapy in blood separation of cardiac aortic surgery

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR-INR-17013121
Enrollment
Unknown
Registered
2017-10-26
Start date
2017-10-30
Completion date
Unknown
Last updated
2017-11-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stanford type A aortic dissection or aortic aneurysm

Interventions

HSA:0.16g/kg huaman serum ablumin
control:Crystal liquid

Sponsors

Department of Anesthesiology, the First Affiliated Hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) Aged 18-0 years old male and female, NYHA functional class 2 to 3; (2) surgical heart surgery is performed under conditions of CPB; (3) informed consents signed; (4) Denied disease history of esophagus and stomach, can be intraoperative TEE operation; (5) normal liver and kidney function; (6) no obvious coagulation dysfunction; (7) Denied disease history of blood system.;Inclusion criteria: (1) Aged 18-0 years old male and female, NYHA functional class 2 to 3; (2) surgical heart surgery is performed under conditions of CPB; (3) informed consents signed; (4) Denied disease history of esophagus and stomach, can be intraoperative TEE operation; (5) normal liver and kidney function; (6) no obvious coagulation dysfunction; (7) Denied disease history of blood system.;Inclusion criteria: (1) Aged 18-0 years old male and female, NYHA functional class 2 to 3; (2) surgical heart surgery is performed under conditions of CPB; (3) informed consents signed; (4) Denied disease history of esophagus and stomach, can be intraoperative TEE operation; (5) normal liver and kidney function; (6) no obvious coagulation dysfunction; (7) Denied disease history of blood system.;Inclusion criteria: (1) Aged 18-0 years old male and female, NYHA functional class 2 to 3; (2) surgical heart surgery is performed under conditions of CPB; (3) informed consents signed; (4) Denied disease history of esophagus and stomach, can be intraoperative TEE operation; (5) normal liver and kidney function; (6) no obvious coagulation dysfunction; (7) Denied disease history of blood system.;Inclusion criteria: (1) Aged 18-0 years old male and female, NYHA functional class 2 to 3; (2) surgical heart surgery is performed under conditions of CPB; (3) informed consents signed; (4) Denied disease history of esophagus and stomach, can be intraoperative TEE operation; (5) normal liver and kidney function; (6) no obvious coagulation dysfunction; (7) Denied disease history of blood system.

Exclusion criteria

Exclusion criteria: (1) Emergency surgery; (2) Hb<130g/L; (3) Who suffered allergic reactions or other serious complications during blood separation or reinfusion; (4) Due to irresistible factors caused by the separated blood can not be returned, so those who can not continue to complete the test; (5) Who claim to exit clinical trials; (6) The investigators considered that it is not advisable to continue to participate in this clinical trial.;Exclusion criteria: (1) Emergency surgery; (2) Hb<130g/L; (3) Who suffered allergic reactions or other serious complications during blood separation or reinfusion; (4) Due to irresistible factors caused by the separated blood can not be returned, so those who can not continue to complete the test; (5) Who claim to exit clinical trials; (6) The investigators considered that it is not advisable to continue to participate in this clinical trial.;Exclusion criteria: (1) Emergency surgery; (2) Hb<130g/L; (3) Who suffered allergic reactions or other serious complications during blood separation or reinfusion; (4) Due to irresistible factors caused by the separated blood can not be returned, so those who can not continue to complete the test; (5) Who claim to exit clinical trials; (6) The investigators considered that it is not advisable to continue to participate in this clinical trial.;Exclusion criteria: (1) Emergency surgery; (2) Hb<130g/L; (3) Who suffered allergic reactions or other serious complications during blood separation or reinfusion; (4) Due to irresistible factors caused by the separated blood can not be returned, so those who can not continue to complete the test; (5) Who claim to exit clinical trials; (6) The investigators considered that it is not advisable to continue to participate in this clinical trial.;Exclusion criteria: (1) Emergency surgery; (2) Hb<130g/L; (3) Who suffered allergic reactions or other serious complications during blood separation or reinfusion; (4) Due to irresistible factors caused by the separated blood can not be returned, so those who can not continue to complete the test; (5) Who claim to exit clinical trials; (6) The investigators considered that it is not advisable to continue to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
colloid osmotic pressure;Cardiac Function;

Countries

China

Contacts

Public ContactAyong Tian;Ayong Tian;Ayong Tian;Ayong Tian;Ayong Tian ;;;;

Department of Anesthesiology, the First Affiliated Hospital of China Medical University;Department of Anesthesiology, the First Affiliated Hospital of China Medical University;Department of Anesthesiology, the First Affiliated Hospital of China Medical University;Department of Anesthesiology, the First Affiliated Hospital of China Medical University;Department of Anesthesiology, the First Affiliated Hospital of China Medical University

tay0626@126.com;tay0626@126.com;tay0626@126.com;tay0626@126.com;tay0626@126.com+86 13940182455;+86 13940182455;+86 13940182455;+86 13940182455;+86 13940182455

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026